azelastine hydrochloride and fluticasone propionate
Generic: azelastine hydrochloride and fluticasone propionate
Labeler: mylan pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
azelastine hydrochloride and fluticasone propionate
Generic Name
azelastine hydrochloride and fluticasone propionate
Labeler
mylan pharmaceuticals inc.
Dosage Form
SPRAY, METERED
Routes
Active Ingredients
azelastine hydrochloride 137 ug/1, fluticasone propionate 50 ug/1
Manufacturer
Identifiers & Regulatory
Product NDC
0378-3458
Product ID
0378-3458_6e1e173a-2d01-4e67-8361-dd30604bc8aa
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA AUTHORIZED GENERIC
Application Number
NDA202236
Marketing Start
2020-04-14
Marketing End
2027-02-28
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
03783458
Hyphenated Format
0378-3458
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
azelastine hydrochloride and fluticasone propionate (source: ndc)
Generic Name
azelastine hydrochloride and fluticasone propionate (source: ndc)
Application Number
NDA202236 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 137 ug/1
- 50 ug/1
Packaging
- 1 BOTTLE in 1 BOX (0378-3458-23) / 120 SPRAY, METERED in 1 BOTTLE
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["NASAL"], "spl_id": "6e1e173a-2d01-4e67-8361-dd30604bc8aa", "openfda": {"unii": ["0L591QR10I", "O2GMZ0LF5W"], "rxcui": ["1797847"], "spl_set_id": ["7b5cc5a0-0d47-46b5-b5fb-eb9cc248ae9e"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 BOX (0378-3458-23) / 120 SPRAY, METERED in 1 BOTTLE", "package_ndc": "0378-3458-23", "marketing_end_date": "20270228", "marketing_start_date": "20200414"}], "brand_name": "Azelastine Hydrochloride and Fluticasone Propionate", "product_id": "0378-3458_6e1e173a-2d01-4e67-8361-dd30604bc8aa", "dosage_form": "SPRAY, METERED", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "0378-3458", "generic_name": "Azelastine Hydrochloride and Fluticasone Propionate", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azelastine Hydrochloride and Fluticasone Propionate", "active_ingredients": [{"name": "AZELASTINE HYDROCHLORIDE", "strength": "137 ug/1"}, {"name": "FLUTICASONE PROPIONATE", "strength": "50 ug/1"}], "application_number": "NDA202236", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_end_date": "20270228", "marketing_start_date": "20200414"}